Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection

JAMA

Volumn 282, Issue 6, 1999, Pages 554-560

  Veenstra, David L ^a   Saint, Sanjay ^b   Sullivan, Sean D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; SULFADIAZINE SILVER;

ARTICLE; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HOSPITAL INFECTION; HUMAN; HYPERSENSITIVITY REACTION; INCIDENCE; META ANALYSIS; MODEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0033546650     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.6.554     Document Type: Article

References (57)

1. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis. 1992;15: 197-208.
2. Maki DG. Infections caused by intravascular devices used for infusion therapy. In: Bistro AI, Waldvogel FA, eds. Infections Associated With Indwelling Medical Devices. 2nd ed. Washington, DC: ASM Press; 1994:155-205.
3. Raad II. Intravascular catheter-related infections. Lancet. 1998;351:893-898.
4. Martin MA, Pfaller MA, Wenzel RP. Coagulase-negative staphylococcal bacteremia: mortality and hospital stay. Ann Intern Med. 1989;110:9-16.
5. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis. 1993;16:778-784.
6. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. JAMA. 1994; 271:1598-1601.
7. Smith RL, Meixler SM, Simberkoff MS. Excess mortality in critically ill patients with nosocomial bloodstream infections. Chest. 1991;100:164-167.
8. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing. JAMA. 1992;267:2072-2076.
9. Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters. Crit Care Med. 1994;22:1729-1737.
10. Nystrom B. Impact of handwashing on mortality in intensive care. Infect Control Hosp Epidemiol. 1994; 15:435-436.
11. Doebbeling BN, Stanley GL, Sheetz CT, et al. Comparative efficacy of alternative handwashing agents in reducing nosocomial infections in intensive care units. N Engl J Med. 1992;327:88-93.
12. Flowers RHD, Schwenzer KJ, Kopel RF, et al. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. JAMA. 1989;261:878-883.
13. Hasaniya NW, Angelis M, Brown MR, Yu M. Efficacy of subcutaneous silver-impregnated cuffs in preventing central venous catheter infections. Chest 1996; 109:1030-1032.
14. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet 1991; 338:339-343.
15. Mimoz O, Pieroni L, Lawrence C, et al. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med. 1996;24:1818-1823.
16. Eyer S, Brummitt C, Crossley K, et al. Catheter-related sepsis. Crit Care Med. 1990;18:1073-1079.
17. Cobb DK, High KP, Sawyer RG, et al. A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med. 1992;327:1062-1068.
18. Pearson ML, for the Hospital Infection Control Practices Advisory Committee. Guideline for prevention of intravascular device-related infections. Am J Infect Control. 1996;24:262-293.
19. Pearson ML, Abrutyn E. Reducing the risk for catheter-related infections. Ann Intern Med. 1997;127: 304-306.
20. Bach A. Clinical studies on the use of antibiotic-and antiseptic-bonded catheters to prevent catheter-related infection. Int J Med Microbiol Virology Parasitol. 1995;283:208-214.
21. Modak SM, Sampath L. Development and evaluation of a new polyurethane central venous antiseptic catheter. Complications Surg. 1992;11:23-29.
22. Tennenberg S, Lieser M, McCurdy B, et al. A prospective randomized trial of an antibiotic-and antiseptic-coated central venous catheter in the prevention of catheter-related infections. Arch Surg. 1997; 132:1348-1351.
23. Maki DC, Stolz SM, Wheeler S, Mermel L. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. Ann Intern Med. 1997;127:257-266.
24. van Heerden PV, Webb SAR, Fong S, Golledge CL, Roberts BL. Central venous catheters revisited. Anaesth Intensive Care. 1996;24:330-333.
25. Hannan M, Juste R, Shankar U, Nightingale C, Azadian B, Soni N. Colonization of triple lumen catheters. Clin Intensive Care. 1996;7:56.
26. Bach A, Bohrer H, Bottiger BW, Motsch J, Martin E. Reduction of bacterial colonization of triple-lumen catheters with antiseptic bonding in septic patients. Anesthesiology. 1994;81:A261.
27. Bach A, Schmidt H, Bottiger B, et al. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother. 1996;37:315-322.
28. Heard SO, Wagle M, Vijayakumar E, et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med. 1998;158:81-87.
29. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter. Chest. 1999;115:1632-1640.
30. Ciresi DL, Albrecht, RM, Volkers PA, Scholten DJ. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg. 1996;62:641-646.
31. Pemberton LB, Ross V, Cuddy P, Kremer H, Fessler T, McGurk E. No difference in catheter sepsis between standard and antiseptic central venous catheters. Arch Surg. 1996;131:986-989.
32. Ramsay J, Nolte F, Schwarzmann S. Incidence of catheter colonization and catheter-related infection with an antiseptic impregnated triple lumen catheter. Crit Care Med. 1994;22:A115.
33. Trazzera S, Stern G, Rakesh B, Sinha S, Reiser P. Examination of antimicrobial-coated central venous catheters in patients at high risk for catheter related infections in a medical intensive care unit and leukemia/ bone marrow transplant unit. Crit Care Med. 1995; 23:A152.
34. George SJ, Vuddamalay P, Boscoe MJ. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anaesthesiol. 1997;14:428-431.
35. Appavu S, McKinney G, Bonness M, Patel S. Does modification of the catheter surface affect the infection rate of triple lumen catheters? Chest 1994;106 (suppl):176S.
36. Logghe C, Van Ossel Ch, D'Hoore W, Ezzedine H, Wauters G, Haxhe JJ. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect. 1997;37:145-156.
37. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999;281: 261-267.
38. Center for Devices and Radiological Health. Potential hypersensitivity reactions to chlorhexidine-impregnated medical devices. FDA Public Health Notice, March 11, 1998. Available at: http:// www.fda.gov/cdrh/chlorhex.html. Accessed August 1, 1998.
39. World Health Organization. Central venous catheters (Arrowguard) recalled: anaphylactic shock. In: Information Exchange System. Geneva, Switzerland: World Health Organization; September 15, 1997. Alert No. 62.
40. Oda T, Junichiro H, Naomi K, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology. 1997;87:1242-1244.
41. Naglie G, Drahn MD, Naimark D, Redelmeier DA, Detsky AS. Primer on medical decision analysis: part 3, estimating probabilities and utilities. Med Decis Making. 1997;17:136-141.
42. Epi Info [computer program]. Version 6. Atlanta, Ga: Centers for Disease Control and Prevention; 1996.
43. Laird NM, Mosteller F. Some statistical methods for combining experimental results. Int J Technol Assess Health Care. 1990;6:5-30.
44. Pittet D, Wenzel RP. Nosocomial bloodstream infections in the critically ill. JAMA. 1994;272:1819-1820.
45. Health Care Financing Administration. Prospective Payment System: Standardizing File. Washington, DC: Dept of Health and Human Services; 1998.
46. Bureau of Labor Statistics. Consumer Price Index for Medical Care. Washington, DC: Bureau of Labor Statistics; 1998.
47. Civetta JM, Hudson-Civetta J, Ball S. Decreasing catheter-related infection and hospital costs by continuous quality improvement. Crit Care Med. 1996; 24:1660-1665.
48. Critchfield GC, Willard KE. Probabilistic analysis of decision trees using Monte Carlo simulation. Med Decis Making. 1986;6:85-92.
49. Doubilet P, Begg CB, Weinstein MC, Braun P, McNeil BJ. Probabilistic sensitivity analysis using Monte Carlo simulation. Med Decis Making. 1985;5:157-177.
50. Torrance GW, Siegel JE, Luce BR. Framing and designing the cost-effectiveness analysis. In: Gold ME, Russell LB, Siegel JE, Weinstein MC, eds. Cost-Effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996:54-81.
51. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programs. 2nd ed. New York, NY: Oxford University Press; 1997.
52. Booth FVM, Cohen IL, Kerins R, Lawler D. Are antibacterially impregnated catheters cost effective? Crit Care Med. 1996;24(suppl 1):A45.
53. National Nosocomial Infectons Surveillance (NNIS) System. Report: data summary from October 1986-April 1998, issued June 1998. Am J Infect Control. 1998;26:522-533.
54. Gillum BS, Graves EJ, Wood E, for the National Center for Health Statistics. National hospital discharge survey: annual summary, 1995. Vital Health Stat 13. 1998;133.
55. Kamal GD, Pfaller MA, Rempe LE, Jebson PJ. Reduced intravascular catheter infection by antibiotic bonding: a prospective, randomized, controlled trial. JAMA. 1991;265:2364-2368.
56. Raad I, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med. 1997;127:267-274.
57. Darouiche R, Raad I, Heard S, et al. A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med. 1999;340:1-8.